OpenEvidence: 6 Things to Know About the AI Tool Used by Half of Physicians

Why It Matters

Broad physician adoption signals AI’s transition from novelty to essential point‑of‑care resource, accelerating evidence‑based decision making and reshaping clinical workflows across major health systems.

Key Takeaways

• Over 50% of U.S. physicians regularly use OpenEvidence.
• Valuation rose to $12 billion after $250 million Series D.
• Free for verified doctors; ads appear on ~5% of queries.
• Integrated into Epic EHR at Mount Sinai, Sutter Health, Cedars‑Sinai.
• Trained solely on peer‑reviewed literature, showing high accuracy.

Pulse Analysis

The rapid uptake of OpenEvidence reflects a broader shift toward AI‑augmented clinical decision support. Physicians are turning to the platform for instant, evidence‑based answers, generating 30 million queries in a single month—a volume that rivals the usage of consumer‑focused chatbots. By training exclusively on peer‑reviewed journals and licensing content from the New England Journal of Medicine and the AMA, OpenEvidence differentiates itself from generic large‑language models that rely on open‑internet data, positioning the tool as a trusted source for point‑of‑care information.

From a business perspective, OpenEvidence’s $12 billion valuation and $250 million Series D round underscore investor confidence in AI‑driven health tech. The company’s freemium model—free for government‑verified physicians with limited ad exposure—creates a low‑friction entry point while generating ancillary revenue. Integration with Epic’s EHR at Mount Sinai, Sutter Health, and Cedars‑Sinai embeds the AI directly into clinicians’ workflow, accelerating adoption and creating a defensible moat against competitors like ChatGPT, which still lags in clinical usage.

Clinically, the platform’s focus on curated, peer‑reviewed literature translates into higher answer accuracy, a claim supported by Mayo Clinic researchers. As health systems embed OpenEvidence deeper into electronic records, physicians can access vetted evidence without leaving the patient chart, potentially reducing diagnostic errors and improving treatment outcomes. The convergence of robust funding, strategic EHR partnerships, and validated accuracy positions OpenEvidence to become a cornerstone of evidence‑based medicine in the coming decade.